A new precision medicine initiative to intensively characterize pulmonary hypertension (PH) and pulmonary vascular disease (PVD) through the use of deep clinical phenotyping and comprehensive “omics” analysis – known as PVDOMICS – will drive a new understanding of PVD and refine the current classification methods, say researchers, based on initial findings.